Drug Topics e-News:
Having trouble viewing this email? View in a browser.
|
You are subscribed to %%list.name%% as %%emailaddr%%. Unsubscribe.
|
to Drug Topics e-News
|
|
|
|
 |
 |
| Newest: Interprofessional communication |
| For pharmacists, from Drug Topics: Continuing education for pharmacists and pharmacy technicians. Go to CE site here |
|
|
|
|
Survey
This month we would like to know...
Does your pharmacy impose a daily quota of filled prescriptions?
• Yes
• No
|
|
|
Only one-fifth of children in Ohio who are prescribed antidepressants complete the recommended mimimum
6-month course of drugs to treat depression, a new study reported. Read full article. |
 |
|
|
 |
A discussion generated by
Drug Topics’ readers, editorial staff, and advisory board
John Lemberger, BS, DPh, practiced pharmacy in Wisconsin and Florida for 35 years. |
Pharmacy practice may be changing on many levels, but this pharmacist's vivid word-pictures remind us that some basic issues have never gone away. Read full article.
|
FDA is alerting healthcare professionals that repackaged intravitreal injections of Roche Holdings' Avastin (bevacizumab) have caused a cluster of serious eye infections in the Miami, Fla., area. Read full article. |
|
Morton Pharmacy, a 79-year-old retail pharmacy chain, is selling a majority of its business to Walgreens because of what Morton executives call a difficult business climate for community pharmacies. Read full article. |
|
|
An antidote indicated for the treatment of acute cyanide poisoning judged to be life-threatening has launched. Read full article.
|
|
FDA has approved icatibant injection (Firazyr, Shire Human Genetic Therapies) for the treatment of acute attacks of hereditary angioedema (HAE) in patients 18 years of age and older. Read full article.
|
|
FDA has approved tapentadol extended-release tablets (Nucynta ER, Janssen Pharmaceuticals), an oral analgesic taken twice daily, for the management of moderate-to-severe chronic pain in adults when a continuous, around-the-clock opioid analgesic is needed for an extended period of time. Read full article.
 |
Meetings and Events
September 26-27, 2011 2nd Annual Pharmaceutical Labeling Summit
Washington, D.C.
Contact:
Jeff Grizzel, Conference Director
FDA News
300 N. Washington St., #200
Falls Church, VA 22046-3431
703-538-7668
[email protected]
www.fdanews.com/PharmaLabeling
October 6-7, 2011 NCPA Diabetes Accreditation
Standards-Practical Applications (DASPA)
Nashville, TN
Contact:
100 Daingerfield Road
Alexandria, VA 22314
800-544-7447
October 8-12 2011 NCPA Annual Convention
Nashville, TN
Contact:
100 Daingerfield Road
Alexandria, VA 22314
800-544-7447
November 29, 2011 NACDS Foundation 13th Annual Dinner
New York, NY
Contact:
Jennifer Sargeant, Manager, Foundation Programs and Education, NACDS
703-837-4224
|
|
|
|
| Contact Us |
Contact a Drug Topics editor Click Here
Contact a Drug Topics sales representative Click Here
Learn about direct mail, reprints and classifieds in Drug Topics Click Here |
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
